BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 34885131)

  • 41. Indolent T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: a review and update.
    Matnani R; Ganapathi KA; Lewis SK; Green PH; Alobeid B; Bhagat G
    Hematol Oncol; 2017 Mar; 35(1):3-16. PubMed ID: 27353398
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Somatic mutations in
    Gao LM; Zhao S; Zhang WY; Wang M; Li HF; Lizaso A; Liu WP
    Cancer Biol Ther; 2019; 20(10):1319-1327. PubMed ID: 31311407
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhanced PD-L1 Expression in LMP1-positive Cells of Epstein-Barr Virus-associated Malignant Lymphomas and Lymphoproliferative Disorders: A Single-cell Resolution Analysis With Multiplex Fluorescence Immunohistochemistry and In Situ Hybridization.
    Kume A; Shinozaki-Ushiku A; Kunita A; Kondo A; Ushiku T
    Am J Surg Pathol; 2022 Oct; 46(10):1386-1396. PubMed ID: 35605962
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transcriptional profiling of Epstein-Barr virus (EBV) genes and host cellular genes in nasal NK/T-cell lymphoma and chronic active EBV infection.
    Zhang Y; Ohyashiki JH; Takaku T; Shimizu N; Ohyashiki K
    Br J Cancer; 2006 Feb; 94(4):599-608. PubMed ID: 16449999
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Spectrum of Epstein-Barr virus-related diseases: a pictorial review.
    Maeda E; Akahane M; Kiryu S; Kato N; Yoshikawa T; Hayashi N; Aoki S; Minami M; Uozaki H; Fukayama M; Ohtomo K
    Jpn J Radiol; 2009 Jan; 27(1):4-19. PubMed ID: 19373526
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Presence of Epstein-Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas.
    Brink AA; Dukers DF; van den Brule AJ; Oudejans JJ; Middeldorp JM; Meijer CJ; Jiwa M
    J Clin Pathol; 1997 Nov; 50(11):911-8. PubMed ID: 9462239
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions.
    Zhang Y; Nagata H; Ikeuchi T; Mukai H; Oyoshi MK; Demachi A; Morio T; Wakiguchi H; Kimura N; Shimizu N; Yamamoto K
    Br J Haematol; 2003 Jun; 121(5):805-14. PubMed ID: 12780797
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Extranodal malignant lymphoma of the upper aerodigestive tract: prevalence of Epstien-Barr virus (EBV) infection in King Chulalongkorn Memorial Hospital.
    Assanasen T; Wannakrairot P; Keelawat S; Ruangvejvorachai P; Pramprayoon N
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S266-73. PubMed ID: 16623040
    [TBL] [Abstract][Full Text] [Related]  

  • 50. How we treat NK/T-cell lymphomas.
    Tse E; Zhao WL; Xiong J; Kwong YL
    J Hematol Oncol; 2022 Jun; 15(1):74. PubMed ID: 35659326
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of the role of Epstein-Barr virus in cases of nodal or extranodal T- and NK-cell lymphoma using eber in situ hybridization.
    Karaarslan S; Hekimgil M; Soydan S; Ertan Y; Doğanavşargil B
    Pol J Pathol; 2015 Jun; 66(2):161-9. PubMed ID: 26247530
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recent advances in the risk factors, diagnosis and management of Epstein-Barr virus post-transplant lymphoproliferative disease.
    Aguayo-Hiraldo P; Arasaratnam R; Rouce RH
    Bol Med Hosp Infant Mex; 2016; 73(1):31-40. PubMed ID: 29421230
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.
    Chan JK; Sin VC; Wong KF; Ng CS; Tsang WY; Chan CH; Cheung MM; Lau WH
    Blood; 1997 Jun; 89(12):4501-13. PubMed ID: 9192774
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extranodal NK/T-cell lymphoma of the nasal cavity developed in a patient with intestinal Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder.
    Furuya G; Abe H; Shinozaki-Ushiku A; Yamashita A; Ihara S; Hirata Y; Chiba A; Fujioka Y; Kurokawa M; Koike K; Fukayama M
    Pathol Res Pract; 2018 Jul; 214(7):1051-1055. PubMed ID: 29843925
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epstein-Barr virus-positive cytotoxic T-cell lymphoma followed by chronic active Epstein-Barr virus infection-associated T/NK-cell lymphoproliferative disorder: a case report.
    Kato S; Miyata T; Takata K; Shimada S; Ito Y; Tomita A; Elsayed AA; Takahashi E; Asano N; Kinoshita T; Kimura H; Nakamura S
    Hum Pathol; 2013 Dec; 44(12):2849-52. PubMed ID: 24012167
    [TBL] [Abstract][Full Text] [Related]  

  • 56. EBV-NK cells interactions and lymphoproliferative disorders.
    Kanegane H; Yachie A; Miyawaki T; Tosato G
    Leuk Lymphoma; 1998 May; 29(5-6):491-8. PubMed ID: 9643562
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Advances in the Study of Chronic Active Epstein-Barr Virus Infection: Clinical Features Under the 2016 WHO Classification and Mechanisms of Development.
    Arai A
    Front Pediatr; 2019; 7():14. PubMed ID: 30805320
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control
    Murer A; Rühl J; Zbinden A; Capaul R; Hammerschmidt W; Chijioke O; Münz C
    mBio; 2019 Jan; 10(1):. PubMed ID: 30647153
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNA profiling of Epstein-Barr virus-associated NK/T-cell lymphomas by deep sequencing.
    Motsch N; Alles J; Imig J; Zhu J; Barth S; Reineke T; Tinguely M; Cogliatti S; Dueck A; Meister G; Renner C; Grässer FA
    PLoS One; 2012; 7(8):e42193. PubMed ID: 22870299
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clonal origin of Epstein-Barr virus (EBV)-infected T/NK-cell subpopulations in EBV-positive T/NK-cell lymphoproliferative disorders of childhood.
    Ohga S; Ishimura M; Yoshimoto G; Miyamoto T; Takada H; Tanaka T; Ohshima K; Ogawa Y; Imadome K; Abe Y; Akashi K; Hara T
    J Clin Virol; 2011 May; 51(1):31-7. PubMed ID: 21377409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.